Published in AJNR Am J Neuroradiol on March 16, 2017
Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (2004) 13.18
The spectrum of neuromyelitis optica. Lancet Neurol (2007) 11.83
The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology (2015) 6.64
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain (2007) 4.82
Brain abnormalities in neuromyelitis optica. Arch Neurol (2006) 4.28
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology (2012) 3.79
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol (2006) 3.26
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation (2012) 3.12
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol (2006) 2.80
Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology (2002) 2.41
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology (2013) 2.34
Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology (2003) 2.28
MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology (2015) 1.74
Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation (2010) 1.60
Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. J Immunol (2008) 1.58
Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler (2011) 1.55
Brain abnormalities in neuromyelitis optica. J Neurol Sci (2011) 1.35
"Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol (2009) 1.33
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology (2009) 1.32
Devic's neuromyelitis optica: a critical review. Arq Neuropsiquiatr (2008) 1.29
Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler (2010) 1.24
The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models. Neuroscience (2004) 1.21
Neuromarketing and consumer neuroscience: contributions to neurology. BMC Neurol (2013) 1.13
Devic's neuromyelitis optica: clinical features and prognostic factors. Neurol Sci (2004) 1.03
Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders. Mult Scler (2011) 1.03
Neuromyelitis optica: effect of gender. J Neurol Sci (2009) 1.01
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies. J Neurol (2013) 0.99
Neuromyelitis optica: a distinct demyelinating disease of the central nervous system. Acta Neurol Scand (2008) 0.96
Conventional and advanced imaging in neuromyelitis optica. AJNR Am J Neuroradiol (2013) 0.92
Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions. BMC Neurol (2013) 0.91
Plasma exchange in severe attacks of neuromyelitis optica. Mult Scler Int (2012) 0.90
Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks. Ann Neurol (2014) 0.90
Experimental models of neuromyelitis optica. Brain Pathol (2014) 0.86
Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid. J Neuroimmunol (2014) 0.82
What do we know about brain contrast enhancement patterns in neuromyelitis optica? Clin Imaging (2015) 0.81
Cortical and leptomeningeal involvement in three cases of neuromyelitis optica. Eur J Neurol (2012) 0.81
Exceeding the limits of the normal blood-brain barrier: quo vadis gadolinium? AJNR Am J Neuroradiol (2007) 0.80
Perivascular Enhancement in a Patient with Neuromyelitis Optica Spectrum Disease during an Optic Neuritis Attack. J Neuroimaging (2014) 0.78
Acute reversible periependymal ventricular enhancement in neuromyelitis optica. Eur J Neurol (2012) 0.78
Asymmetry of the Odontoid Lateral Mass Interval in Pediatric Trauma CT: Do We Need to Investigate Further? AJNR Am J Neuroradiol (2015) 0.75
Emergency Department MRI Scanning of Patients with Multiple Sclerosis: Worthwhile or Wasteful? AJNR Am J Neuroradiol (2016) 0.75